These skin changes developed during treatment for end-stage renal failure. What is the diagnosis?: (A) Amyloidosis, (B) Nephrogenic fibrosing dermopathy, (C) Syphilis, (D) Scleroderma
Answer is B. Answer B. Nephrogenic fibrosing dermopathyNephrogenic fibrosing dermopathy is characterized by diffuse, cutaneous, hyperpigmented, brawny induration, erythematous or skin-colored plaques with irregular borders. The cause of nephrogenic fibrosing dermopathy is unknown.